None
EN
USANA Health Sciences (NYSE:USNA) Issues FY 2026 Earnings Guidance
['Latisha Jones']
Daily Political
USANA Health Sciences (NYSE:USNA – Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday morning.
Get USANA Health Sciences alerts:Get Our Latest Analysis on USNAUSANA Health Sciences Price PerformanceShares of USNA traded up $0.05 during trading hours on Tuesday, reaching $22.89.
USANA Health Sciences had a return on equity of 6.21% and a net margin of 0.96%.USANA Health Sciences has set its FY 2026 guidance at 0.760-0.760 EPS.
USANA Health Sciences Company Profile(Get Free Report)USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors.
Read MoreReceive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.